| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |